Detalhe da pesquisa
1.
Artificial intelligence for predictive biomarker discovery in immuno-oncology: a systematic review.
Ann Oncol
; 35(1): 29-65, 2024 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-37879443
2.
Efficacy of front-line treatment for hormone receptor-positive HER2-negative metastatic breast cancer with germline BRCA1/2 mutation.
Br J Cancer
; 128(11): 2072-2080, 2023 06.
Artigo
Inglês
| MEDLINE | ID: mdl-37012318
3.
Risk-adapted modulation through de-intensification of cancer treatments: an ESMO classification.
Ann Oncol
; 33(7): 702-712, 2022 07.
Artigo
Inglês
| MEDLINE | ID: mdl-35550723
4.
Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer.
Ann Oncol
; 33(12): 1250-1268, 2022 12.
Artigo
Inglês
| MEDLINE | ID: mdl-36228963
5.
Breast Cancer Patients' Experience and Wishes Regarding Communication on Sexual Health: The BEROSE Study.
Cancer Invest
; 40(6): 483-493, 2022 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-35468006
6.
Trastuzumab emtansine (T-DM1) in patients with HER2-positive metastatic breast cancer and brain metastases: exploratory final analysis of cohort 1 from KAMILLA, a single-arm phase IIIb clinical trialâ.
Ann Oncol
; 31(10): 1350-1358, 2020 10.
Artigo
Inglês
| MEDLINE | ID: mdl-32634611
7.
OlympiAD final overall survival and tolerability results: Olaparib versus chemotherapy treatment of physician's choice in patients with a germline BRCA mutation and HER2-negative metastatic breast cancer.
Ann Oncol
; 30(4): 558-566, 2019 04 01.
Artigo
Inglês
| MEDLINE | ID: mdl-30689707
8.
Differential impact of endocrine therapy and chemotherapy on quality of life of breast cancer survivors: a prospective patient-reported outcomes analysis.
Ann Oncol
; 30(11): 1784-1795, 2019 11 01.
Artigo
Inglês
| MEDLINE | ID: mdl-31591636
9.
Effects of neratinib on health-related quality of life in women with HER2-positive early-stage breast cancer: longitudinal analyses from the randomized phase III ExteNET trial.
Ann Oncol
; 30(4): 567-574, 2019 04 01.
Artigo
Inglês
| MEDLINE | ID: mdl-30689703
10.
T-cell bispecific antibodies in node-positive breast cancer: novel therapeutic avenue for MHC class I loss variants.
Ann Oncol
; 30(6): 934-944, 2019 06 01.
Artigo
Inglês
| MEDLINE | ID: mdl-30924846
11.
Pertuzumab, trastuzumab, and standard anthracycline- and taxane-based chemotherapy for the neoadjuvant treatment of patients with HER2-positive localized breast cancer (BERENICE): a phase II, open-label, multicenter, multinational cardiac safety study.
Ann Oncol
; 29(3): 646-653, 2018 03 01.
Artigo
Inglês
| MEDLINE | ID: mdl-29253081
12.
Modulation of Rb phosphorylation and antiproliferative response to palbociclib: the preoperative-palbociclib (POP) randomized clinical trial.
Ann Oncol
; 29(8): 1755-1762, 2018 08 01.
Artigo
Inglês
| MEDLINE | ID: mdl-29893769
13.
Letrozole and palbociclib versus chemotherapy as neoadjuvant therapy of high-risk luminal breast cancer.
Ann Oncol
; 29(12): 2334-2340, 2018 12 01.
Artigo
Inglês
| MEDLINE | ID: mdl-30307466
14.
ESMO Guidance for Reporting Oncology real-World evidence (GROW).
Ann Oncol
; 34(12): 1097-1112, 2023 12.
Artigo
Inglês
| MEDLINE | ID: mdl-37848160
15.
[Mastectomy and immediate reconstruction: Indications, techniques and decision algorithm]. / Mastectomie avec reconstruction mammaire immédiate : indications et techniques, algorithme de décision d'une reconstruction immédiate.
Ann Chir Plast Esthet
; 63(5-6): 542-544, 2018 Nov.
Artigo
Francês
| MEDLINE | ID: mdl-30144962
16.
A randomized adaptive phase II/III study of buparlisib, a pan-class I PI3K inhibitor, combined with paclitaxel for the treatment of HER2- advanced breast cancer (BELLE-4).
Ann Oncol
; 28(2): 313-320, 2017 02 01.
Artigo
Inglês
| MEDLINE | ID: mdl-27803006
17.
New oral targeted therapies for metastatic breast cancer disrupt the traditional patients' management-A healthcare providers' view.
Eur J Cancer Care (Engl)
; 26(6)2017 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-28026083
18.
Paclitaxel plus bevacizumab or paclitaxel as first-line treatment for HER2-negative metastatic breast cancer in a multicenter national observational study.
Ann Oncol
; 27(9): 1725-32, 2016 09.
Artigo
Inglês
| MEDLINE | ID: mdl-27436849
19.
Therapy-related myeloid neoplasms following treatment with PARP inhibitors: new molecular insights.
Ann Oncol
; 32(8): 1046-1048, 2021 08.
Artigo
Inglês
| MEDLINE | ID: mdl-34107346
20.
A preoperative nomogram to predict the risk of synchronous distant metastases at diagnosis of primary breast cancer.
Br J Cancer
; 112(6): 992-7, 2015 Mar 17.
Artigo
Inglês
| MEDLINE | ID: mdl-25668007